Jun 26, 2025, 12:58
Welcoming Opposition to ISTH 2025: EHC Highlights the Crucial Role of Modern Treatments in Hemophilia Management
The European Haemophilia Consortium shared a post on X:
”The EHC attended ISTH 2025, where Maria Elisa Mancuso & Mark Skinner presented manuscripts we co-authored opposing the ISTH Guidelines. Thanks, Maria Elisa Mancuso (EHC Medical Advisory Group Chair), for representing our community at this pivotal moment!”
Apparently, no field is safe from a clash of clans!
The European Haemophilia Consortium eagerly took the stage to brand the ISTH guidelines as “outdated and purposeless” when it comes to acknowledging ”Modern Hemophilia Treatments”.
Maria Elisa Mancuso, Chair of the EHC Medical Advisory Group, and Mark Skinner presented sharply contrasting manuscripts that stirred the debate.
Stay updated on the World of Hemophilia with Hemostasis Today.
-
Jul 8, 2026, 21:30Matthew Gouveia: How VNS-REHAB Is Transforming the Future of Stroke Rehabilitation
-
Jul 8, 2026, 21:22What Hundreds of Stroke Stories Have Taught Diana Kerr About Recovery and Resilience – Stroke Foundation
-
Jul 8, 2026, 19:50Heghine Khachatryan: Why the EHC Fully Supports the Lancet Commission on Women’s Hematological Health
-
Jul 8, 2026, 19:40Autoregulation Failure in SVD and Cognitive Impairment – International Journal of Stroke
-
Jul 8, 2026, 19:30Ahmed Mostafa: Why Antibodies Cause Organ Rejection
-
Jul 8, 2026, 19:28Erika Bocanegra: Witnessing 25 Years of Progress in Bleeding Disorders Care
-
Jul 8, 2026, 19:27Ahmadou Ouedraogo: Do You Know Your Blood Type?
-
Jul 8, 2026, 19:26Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
-
Jul 8, 2026, 19:25Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research